GABAPENTIN
NDC 31722-166, Gabapentin, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-166
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214957
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN600 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-166-01 | 31722016601 | 100 TABLET in 1 BOTTLE (31722-166-01) |
| 31722-166-05 | 31722016605 | 500 TABLET in 1 BOTTLE (31722-166-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9ead7825-d11b-4e00-8533-328d097b8f83NADAC price for package 31722016601
GET /v1/drugs/nadac/31722016601NADAC price for package 31722016605
GET /v1/drugs/nadac/31722016605
Use it
Look up 31722-166 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-166. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.